Latest From Biotech Now

BIO Patient & Health Advocacy Summit: The Power of Partnerships

patient-summit-4

Last week, the BIO Patient & Health Advocacy Summit powered partnerships in the industry to advance drug discovery by bringing together patient and advocacy groups, government agencies and biotech industry leaders to discuss how to accelerate medical R&D, preserve patient access to appropriate care, leverage data and build collaborations focused on empowering patients. The rallying cry that reverberated throughout the event and over Twitter seemed clear from the beginning and Paul Hastings, Chairman and CEO Read More >

Events, Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Get to Know GMOs Month Continues with the Science Behind GMOs

GMO Answers

During the month of October, GMO Answers encourages you to Get to Know GMOs. Ask your questions and join the conversation online. Each week we’re posting new information to help you get to know GMOs and better understand the role of biotechnology in agriculture. For week one we discussed the biggest misconceptions about GMOs and for week two we covered GMO basics. Moving into week three now, we’re demystifying the science of GMOs, showing how science is used to ensure the safety Read More >

Farmer Gene  |  Leave a comment  |  Email This Post
Tags: , ,

BIO Submits Joint Supplemental Comments on the USPTO March Guidance

Supreme Court

Last week BIO, alongside a number of member companies and private individuals, submitted supplemental comments to the U.S. Patent and Trademark Office concerning their March 2014 Guidance on patent subject matter eligibility. In July, BIO and international bio-industry associations had submitted comments to the USPTO expressing concern about the Guidance, and its impact on the patent eligibility of biotechnology inventions. Since July, USPTO staff has indicated a final revision to the Guidance would be released Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , , , , , , , , , , , ,

BIO Member Company Achieves Significant Milestone in Advanced Biofuel Technology

abengoa-fermentation-tank-115x76

On Friday, October 17, 2014, Abengoa Bioenergy opened its 25-million gallon per year cellulosic ethanol biorefinery in Hugoton, Kansas.  Abengoa completed the construction of its facility in mid-August and began producing cellulosic ethanol at the end of September. The plant produces up to 25 million gallons a year using only raw biomass “second generation” for the production of ethanol, ie residues of agricultural crops and inedible stems and leaves that do not compete with grain for feed materials. Through Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , , , , ,

Richard Pops: A Greater Patient Voice in Drug Development

ph-summit

In the October issue of MedNous, Alkermes’ CEO Richard Pops writes about the move toward increased engagement with patients in the development, review and delivery of new medicines, as well as the challenges and opportunities associated with access and reimbursement. Pops asserts that patients must organize to share data that can be used in regulatory decision-making. Furthermore, he writes that this input must be integrated through the process – from the early stages of development Read More >

Events, Health, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , ,